The University of Oxford on Tuesday said there was no substantiation that vaccines would not help severe complaint from Omicron, but that it was ready to fleetly develop an streamlined interpretation of its vaccine developed with AstraZeneca (AZN.L) if necessary.
Before on Tuesday, the head of drugmaker Moderna said that COVID-19 shots were doubtful to be as effective against the variant, jarring global requests.
The University of Oxford said that there was limited data on Omicron so far, and that it would precisely estimate the impact of the variant on its shot, echoing an AstraZeneca statement last week.
“Despite the appearance of new variants over the once time, vaccines have continued to give veritably high situations of protection against severe complaint and there’s no substantiation so far that Omicron is any different,”it said in a statement.
” Still, we’ve the necessary tools and processes in place for rapid-fire development of an streamlined COVID-19 vaccine if it should be necessary.”
